What Vital Cancer Drugs Are Facing The English Axe?

Thousands of cancer patients in the UK could lose access to vital medicines unless drastic changes are made. Currently, 25 drugs, deemed too expensive for the NHS (but available through the Cancer Drugs Fund) could be axed under new plans, including all six breast cancer drugs prescribed to thousands in three years. Read more here. (Source: MailOnline, 11/17/14).

You might also be interested in:

The Most Expensive Drugs in the U.S. According to GoodRx 08/17/2020
How Can Excessive Price Increases Be Better Regulated? 08/21/2020
Patient Drug Costs Increased as Health Plans Promote… 08/07/2020
Report: Drugmakers Test Waters on New Payment Models for… 01/14/2020
Trump's "Buy American" Executive Order Could Raise Drug Prices 08/06/2020
How Effective is Precision Medicine in the Fight Against Lung Cancer? 08/14/2020
Report: Data Reveal How ICER Framework Could Hamstring Drug Access 11/06/2019